AlphAIalphai — Financial news for AI agents
SEC EDGAR 8-KAUG 44 min read$AME

AMETEK INC/ (AME): Results of Operations and Financial Condition

AMETEK INC/ (AME) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 ametek8kexhibit99108042026.htm EX-99.1 Document Exhibit 99.1 AMETEK Announces Record Second Quarter 2026 Results and Raises Full Year Guidance Berwyn, Pa., Aug 4, 2026 – AMETEK, Inc. (NYSE: AME) today announced its financial results for the second quarter ended June 30,

Original reporting
SEC EDGAR 8-K
Published Aug 4, 2026, 1:56 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 4, 2026, 1:59 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About alphai AI DeskScoring methodologyReport an issue
alphai market briefEarnings
Primary signal
$AME
Bullish
high confidence
Mentioned
$AME
Relevance
7/10
alphai data visualization · based on SEC EDGAR 8-K
Decision brief

The 30-second read

$AMEBullishHigh
01

Why it matters

The key tradable items are the raised full-year adjusted EPS range and the Q3 adjusted EPS range, supported by record sales, record GAAP and adjusted EPS, higher operating margins, and strong orders growth.

02

Market read

Record Q2 performance plus a higher FY 2026 adjusted EPS range is a direct catalyst for earnings expectations and valuation.

03

What to watch

The release emphasizes adjusted metrics; traders may scrutinize GAAP-to-adjusted differences and whether cash flow conversion remains elevated into H2.

Relevance 7/10Novelty 9/10Timing: guidance update filed pre-market Aug 4, 2026

Background

This is an SEC Form 8-K (Item 2.02) with AMETEK’s Q2 2026 results and updated Q3 and full-year 2026 outlook.

Company-level read

Ticker impact

$AMEBullishHigh confidence
Context

AMETEK reported record Q2 2026 sales of $2.04B, GAAP EPS $1.77, and raised full-year adjusted EPS guidance to $8.20 to $8.30.

Expected impact

Likely positive near-term bias as traders price the higher 2026 EPS range and strong order growth.

Evidence & confidence

The filing is a primary disclosure (8-K) with specific, time-bound guidance changes and multiple corroborating operating metrics (orders +28%, core margin expansion, strong cash flow).

Market effects

Sector

Strength in orders and margins supports the broader industrial technology demand narrative, particularly for electronics and electromechanical end markets.

Regional

No explicit regional demand shock cited; impact is primarily company-specific.

Global

Secular infrastructure and aerospace/semiconductor demand tailwinds are referenced, but no new macro/regional data is provided.

Counterpoint

What could challenge this read

Guidance upside may already be partially anticipated; investors could focus on sustainability of order growth and integration-related costs.

Key entities

  • public_company
    AMETEK, Inc.

    Industrial technology company reporting Q2 2026 results and raising 2026 guidance in an 8-K.

  • business_segment
    Electronic Instruments Group (EIG)

    Segment with Q2 sales $1.32B and adjusted operating income up 12%.

  • business_segment
    Electromechanical Group (EMG)

    Segment with Q2 sales $723.2M and adjusted operating income up 32%.

  • executive
    David A. Zapico

    Chairman and CEO quoted on record results, orders growth, and guidance.

Read at source← All news

Related articles

AUG 5
$AMEMed

Segment Demand and Strategic Acquisitions Propel Growth

AMETEK (NYSE: AME) reported Q2 CY2026 revenue of $2.04 billion, up 15% year over year, beating Wall Street expectations. Non-GAAP EPS was $2.09, 4.8% above consensus. Management cited organic growth, rising orders and backlog of $4.11 billion, and contributions from acquisitions. Full-year guidance was raised, supported by AI, defense, and power grid demand.

financialcontent.com4 min
AUG 4
$AMEMedAI 8/10

AMETEK, Inc. Q2 2026 Earnings Call Summary

AMETEK reported Q2 2026 momentum driven by multi-year infrastructure build-outs for AI, semiconductors, and power. Organic sales growth accelerated, with a record $4.11B backlog and about 80% expected to ship in 12 months. Core EMG margins rose 290 bps. Full-year 2026 organic sales guidance was raised to mid-to-high single digits; Indicor Instrumentation acquisition of $5B expected to close in H2 with 10% to 12% synergies.

yahoo.com7 min
AUG 4
$AMEMedAI 8/10

AMETEK’s (NYSE:AME) Q2 CY2026: Strong Sales

AMETEK (NYSE:AME) reported Q2 CY2026 revenue of $2.04 billion, up 15% year on year, exceeding Wall Street estimates by 4.4%, according to the company. Non-GAAP adjusted EPS was $2.09, up from $1.78 and 4.8% above consensus. Analysts expect full-year EPS of $8.46, up from $7.96.

financialcontent.com3 min
AUG 8
$SHOPMedAI 8/10

Shopify Was Supposed to Be an AI Casualty. Its AI-Referred Traffic Just Tripled.

Shopify (SHOP) reported Q2 results, citing AI-referred traffic to merchants’ storefronts that tripled year over year and orders that began with AI search also tripled. New buyers from AI channels placed orders at nearly twice the rate of other channels. Revenue rose 34% to $3.6B, GMV reached $115.6B, operating income rose 68% to $488M, and free cash flow was $654M.

yahoo.com6 min
AUG 8
$GPRKMed

Geopark Q2 Earnings Call Highlights

Geopark (NYSE:GPRK) reported Q2 earnings call updates. It plans $40m to $50m of Vaca Muerta investment in 2H 2026 after $55m in 1H, with 70% to 80% in Q3. Full-year lifting costs are guided at $17 to $19/bbl. Cash rose to $316m, net leverage fell to 1.2x EBITDA, and a $0.023/share quarterly dividend was declared.

yahoo.com6 min